Allurion Technologies expands Virtual Care Suite to the U.S.

Allurion Technologies announced the commercial availability of its comprehensive Virtual Care Suite, VCS, in the United States. Already in use by thousands of providers in over 50 countries, the VCS is a dynamic weight-loss management suite powered by artificial intelligence featuring remote patient monitoring, telehealth and care team collaboration all under the one digital umbrella, designed to maximize patient outcomes and satisfaction. “After witnessing the profound impact our technology has had globally, we are thrilled to launch the VCS in the United States. Our team is incredibly excited to provide US clinics with digital solutions to help them significantly bolster both clinical outcomes and patient experience for all weight-loss treatments, including anti-obesity medications and bariatric surgery, especially as GLP-1 usage surges,” said Brian Conyer, Vice President of Digital Health. “Our research indicates that the VCS has already enhanced patient results, engagement, and satisfaction. Clinics with the highest VCS usage achieve an additional 11% weight loss1, with 16% more patients reaching their goals1, and a 17% increase in Net Promoter Score (NPS)2.”